• Innocan Pharma Announces Patent Application for Novel Cannabis-Based Psoriasis Treatment
    Read more
  • InnoCan Pharma unterzeichnet Absichtserklärung zur Entwicklung und Herstellung von Exosomen für den Einsatz im Rahmen seiner Therapien mit CBD beladenen Exosomen (CLX)
    Read more
  • InnoCan Pharma Enters into Letter of Intent to Develop and Produce Exosomes for Use in its CBD-Loaded Exosome (CLX) Treatments
    Read more
  • Innocan Pharma Announces Pricing of Marketed Short Form Prospectus Offering of Units
    Read more
  • Innocan Pharma Announces up to $10 Million Public Offering of Units
    Read more
  • InnoCan Announces Appointment of Professor Daniel Offen, Scientific Advisory Director
    Read more
  • InnoCan to Develop a New Lines of CBD Products for Tamar Technologies
    Read more
  • InnoCan Pharma Collaborates with Tel Aviv University to Develop a New Revolutionary Approach to Treat the COVID-19 Corona Virus with Exosomes-Loaded CBD
    Read more
  • InnoCan Provides Update and Summary About Its Corporate Progress as Its First Products Prepare to Enter the Commercial Marketplace
    Read more
  • InnoCan Pharma Announces Patent Application for Novel Hemorrhoid Treatment
    Read more
  • InnoCan Signs its First Distribution Agreement with "Active Therapeutics" for InnoCan's CBD Derma Cosmetics products in the United Kingdom and Ireland
    Read more
  • InnoCan Announces Appointment of Prominent Healthcare Executive, Peter Bloch as a Director
    Read more
  • InnoCan Announces It Has Executed A Research & License Agreement With The Commercial Arm Of The Hebrew University
    Read more
  • InnoCan Announces Successful Research Study Advancing Its Development of Cannabidiol Targeted Injection Delivery Platform
    Read more
  • INNOCAN SIGNS AGREEMENT TO MANUFACTURE PRODUCTS IN THE U.S.
    Read more
  • INNOCAN PHARMA SIGNS AN AGREEMENT WITH FANCYSTAGE UNIPESSOAL LDA
    Read more
  • INNOCAN PHARMA PLANS TO ENTER CBD BEAUTY MARKET WITH LAUNCH OF INNOCAN BRANDED COSMETIC PRODUCTS IN H1/20
    Read more
  • INNOCAN PHARMA ANNOUNCES PATENT APPLICATION TO ENABLE CBD TARGETED INJECTIONS
    Read more
  • Innocan Pharma Corporation Announces Closing of Initial Public Offering and Listing on Canadian Securities Exchange Under the Symbol “Inno”
    Read more